Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate Update |
Globe Newswire |
07/30 |
11:00 |
Rogers Communications Reports Second Quarter 2024 Results |
Globe Newswire |
07/24 |
11:00 |
DraftKings Plans to Launch Mobile Sports Betting in Washington D.C. |
Globe Newswire |
07/23 |
11:30 |
Gray Media Partners with Harlem Globetrotters for their Historic Return to Live Television Across the Nation for First Time in 40 Years |
Globe Newswire |
07/18 |
20:15 |
Sportradar to Release Second Quarter Financial and Operational Results on August 13, 2024 |
Globe Newswire |
07/17 |
12:00 |
DraftKings to Release Second Quarter 2024 Results on August 1, 2024 and Host Conference Call on August 2, 2024 |
Globe Newswire |
07/15 |
20:15 |
Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Update |
Globe Newswire |
07/11 |
20:00 |
UEFA and Sportradar Extend and Expand Partnership to Continue Providing Bettors and Fans with Unparalleled, Innovative Engagement |
Globe Newswire |
07/11 |
10:00 |
CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet |
Globe Newswire |
07/10 |
12:00 |
Big 12 Conference Selects TuneIn as the New Home for Conference Audio Coverage |
Globe Newswire |
07/09 |
13:00 |
Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board |
Globe Newswire |
07/09 |
12:00 |
HUTCHMED Announces NDA Acceptance in China for Tazemetostat for the Treatment of Relapsed or Refractory Follicular Lymphoma with Priority Review Status |
Globe Newswire |
07/04 |
00:00 |
Sportradar Secures Major Client Wins on Strength of Managed Trading Services |
Globe Newswire |
07/01 |
07:00 |
Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma |
Globe Newswire |
06/28 |
11:00 |
Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Refractory Follicular Lymphoma |
Globe Newswire |
06/28 |
06:00 |
Garth Brooks’ The BIG 615, Tractor Supply Company and TuneIn Team Up to Host 48-Hour ‘TuneIn to Give Back’ Radiothon for Folds of Honor |
Globe Newswire |
06/27 |
13:00 |
Xtract One Technologies Selected by NHL’s Stanley Cup Winning Florida Panthers to Secure Entrances at Amerant Bank Arena, Baptist Health IcePlex, and FTL War Memorial |
Globe Newswire |
06/27 |
11:05 |
Jet.AI Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants |
Globe Newswire |
06/27 |
11:00 |
Marlin Spring Developments and Greybrook Celebrate Inauguration of Dale Hawerchuk Park at Symphony Towns |
Globe Newswire |
06/25 |
19:00 |
TuneIn Expands Global In-Vehicle Availability with Great Wall Motor Partnership |
Globe Newswire |
06/25 |
17:05 |
Tradable Bits Debuts New Games for its Industry-leading ARCADE Interactive Fan Engagement Platform in Collaboration with MLSE Digital Labs |
Globe Newswire |
06/24 |
13:00 |
Kiniksa Pharmaceuticals Partners with NHL Hall-of-Famer Henrik Lundqvist to Raise Awareness of Recurrent Pericarditis |
Globe Newswire |
06/24 |
12:00 |
Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and LRRK2 |
Globe Newswire |
06/21 |
11:00 |
Garth Brooks’ The BIG 615 and TuneIn Launch ‘The StormeCast’ Podcast with Host Storme Warren |
Globe Newswire |
06/20 |
17:10 |
Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024) |
Globe Newswire |
06/16 |
09:30 |